We like its restructuring, and we see growth and a higher stock price ahead.
Jim Cramer says Mario Draghi's comments are responsible for sending the S&P 500 surging past 2,000 for the first time.
Jim Cramer says Roche's $8.3 billion bid for U.S. biotech firm InterMune means big pharma is thinking big.
Jim Cramer answers viewers' Twitter questions from the floor of the New York Stock Exchange.
The acquisition is a symbol of a much bigger trend.
We like the cheap valuations and growth potential.
The deal reached on MBS is positive for the bank.
Catch up on Jim Cramer's thinking over the last week about Bank of America's settlement and using trains as an indicator.
We are keeping our strategy focused on industrials, financials and technology.
We like the rate play, the new management team, the simpler structure and cheap valuation.